SCHEMBL29623281

SCHEMBL29623281

N#Cc1c(Cl)ncnc1NCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
HPGD P15428 3/20 0.54
KDM4E B2RXH2 2/20 0.54
TSHR P16473 7/20 0.54
LMNA P02545 5/20 0.54
HTT P42858 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MAPK10 P53779 1/20 0.54
EGFR P00533 3/20 0.50
GALR3 O60755 2/20 0.50
NR2F2 P24468 2/20 0.50
ABCC1 P33527 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
RAB9A P51151 1/20 0.50
KDM4C Q9H3R0 1/20 0.49
MAPK1 P28482 4/20 0.49
CYP1A2 P05177 4/20 0.47
CYP2D6 P10635 4/20 0.47
CYP3A4 P08684 3/20 0.47
USP2 O75604 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23204279 1.00 ALDH1A1 (0.54) ALDH1A1HPGDKDM4ETSHRLMNA
SCHEMBL23162580 0.86 TAAR1 (0.56) ALDH1A1HPGDKDM4ELMNAHTT
SCHEMBL23162568 0.83 LMNA (0.52) ALDH1A1HPGDKDM4ETSHRLMNA
SCHEMBL29623213 0.83 LMNA (0.52) ALDH1A1HPGDKDM4ETSHRLMNA
SCHEMBL4269335 0.78 EGFR (0.52) ALDH1A1HPGDKDM4ESMN1; SMN2EGFR
SCHEMBL8243683 0.78 PGK1 (0.41) ALDH1A1HPGDKDM4EGALR3HSD17B10
SCHEMBL11110157 0.77 EGFR (0.57) ALDH1A1TSHRLMNAHTTSMN1; SMN2
SCHEMBL30983851 0.77 KDM4C (0.72) ALDH1A1HPGDKDM4ETSHRLMNA
SCHEMBL783719 0.77 KDM4C (0.72) ALDH1A1HPGDKDM4ETSHRLMNA
SCHEMBL4032806 0.77 EGFR (0.54) ALDH1A1HPGDTSHRLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450277-A Substituted pyrimidines for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2022-05-06 CN disclosed